At AACR 2026, scientists showcased advances in radiotherapeutics, antibody-drug conjugates, T cell engagers, and ...

We're a far cry from the soft, warm amber and yellow of sealed-beam headlights, and while we shouldn't pretend they were perfect, they didn't cause retina sparks either. The main reason manufacturers ...

LED headlights dominate the industry due to efficiency and longevity. HIDs are brighter but have drawbacks like flickering and slower start-up. Halogen bulbs are less efficient, shorter-lived, and ...

Alzheimer's disease (AD) is a highly debilitating neurodegenerative disease characterized by the progressive loss of memory and decline of mental functions. Earlier research has uncovered some of the ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Next-generation nuclear power plants may include exciting novel designs in which molten salts are the coolant or a combination of the coolant and fuel. Whereas it is straightforward to see why having ...

There are several reasons why you're better off sticking with the stock halogen or high-intensity discharge (HID) bulbs in your car, rather than replacing them with cheap aftermarket LED headlights.

Third fund taps into a $7.5-trillion market opportunity to provide solutions for modern families Halogen Ventures, Jesse Draper’s venture capital firm focused on early-stage startups with a woman on ...

Noncovalent interactions are indispensable to chemical science and crucial to fostering new perspectives on molecular structure and reactivity. In this pursuit, halogen bonding has been the object of ...

Halogen Ventures closed a $30 million Fund III to invest in early-stage startups building in the “future of family,” as reported first by Fortune. The firm was founded in 2015 by Jesse Draper, the ...

A novel application of deep learning (DL)-based MRI with liquid biomarkers for immune effector cell-associated neurotoxicity syndrome (ICANS) after chimeric antigen receptor (CAR) T-cell therapy. This ...